AMCR vs AVY vs DSS Stock Comparison

Amcor, Avery Dennison and Dss Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (TRS) Create a free account to keep reading and compare up to 10 companies.
AMCR Amcor plc
$47.12 +10.9% 1M +17.8% 1Y
Market cap
$21.79B
P/E
19.7x
Revenue (TTM)
$23.51B
Div. yield
11.04%
Plastic Packaging Basic Materials
6 wins
AVY Avery Dennison Corp
$182.12 +6.6% 1M +3.4% 1Y
Market cap
$13.82B
P/E
19.6x
Revenue (TTM)
$9.36B
Div. yield
2.13%
Specialty Chemicals Basic Materials
4 wins
DSS Dss, Inc.
$0.52 -26.8% 1M -56.3% 1Y
Market cap
$5.22M
P/E
–
Revenue (TTM)
$18.17M
Div. yield
–
Paper Packaging Basic Materials
1 win

Head to Head

11 decided of 12

Amcor leads on 6 of the 12 questions below (Amcor 6, Avery Dennison 4, Dss 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionAMCRAVYDSSLeader
Larger companyMarket capitalisation $21.79B $13.82B $5.22M AMCR
Cheaper on earningsLower P/E, profitable companies only 19.7x 19.6x -0.3x AVY
Cheaper on forward earningsLower price / next fiscal year consensus EPS 11.4x 17.2x — AMCR
Faster revenue growthRevenue growth, trailing twelve months +56.6% +6.8% -63.2% AMCR
More profitableNet margin, trailing twelve months 4.7% — -96.5% AMCR
Better return on capitalReturn on invested capital 6.1% — — –
Less leveragedLower net debt / EBITDA 3.8x — -2.2x DSS
Higher dividend yieldTrailing dividend yield 11.04% 2.13% — AMCR
Better 1-year returnPrice return, last 12 months +17.8% +3.4% -56.3% AMCR
Better 5-year returnAnnualised price return, 5 years -4.8%/yr -3.5%/yr -53.1%/yr AVY
Less volatileAnnualised volatility, 1 year 31.4% 23.4% 102.8% AVY
Higher overall scoreMean of the five percentile scores vs peers 66/100 69/100 10/100 AVY

Percentile Scorecard

AMCRAVYDSS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisAMCRAVYDSS
Valuation 38 #11 of 17 61 #37 of 94 0 #17 of 17
Growth 93 #2 of 16 84 #16 of 92 40 #10 of 16
Profitability 71 #5 of 15 91 #9 of 86 0 #15 of 15
Financial Health 36 #10 of 15 – 0 #15 of 15
Shareholder Returns 92 #2 of 14 40 #43 of 71 8 #13 of 14
Overall 66 69 10
  • AMCR ranked among 17 companies in Packaging
  • AVY ranked among 99 companies in Chemicals
  • DSS ranked among 17 companies in Packaging

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodAMCRAVYDSSSPY
1 month +10.9%+6.6%-26.8% +0.7%
3 months +4.3%+4.2%+4.0% +3.7%
6 months +23.9%+11.1%-5.5% +7.1%
Year to date +13.0%+0.1%-44.1% +12.8%
1 year +17.8%+3.4%-56.3% +11.9%
3 years +6.4%+5.5%-83.9% +85.2%
3 years, per year +2.1%+1.8%-45.6% +22.8%
5 years -21.9%-16.4%-97.7% +67.6%
5 years, per year -4.8%-3.5%-53.1% +10.9%
10 years —+165.4%-99.8% +262.0%
10 years, per year —+10.3%-47.4% +13.7%

Risk

MeasureAMCRAVYDSSSPY
Volatility, 1Y 31.4%23.4%102.8% 12.7%
Downside volatility, 1Y 28.5%21.6%107.4% 12.6%
Beta vs S&P 500, 1Y 0.810.480.17 1.00
Return / volatility, 1Y 0.570.14-0.55 0.94
Max drawdown, 5Y -45.6%-33.3%-98.2% -25.4%
From 52-week high -6.8%-7.8%-62.6% -1.2%
52-week high $50.58$197.45$1.39 $779.14
52-week low $36.69$153.01$0.42 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleAMCRAVYDSS
P/E now vs peer median 19.7xmedian 19.7x 19.6xmedian 21.0x -0.3xmedian 19.7x
P/S now vs peer median 0.9xmedian 0.7x 1.5xmedian 1.4x 0.3xmedian 0.7x
EV/EBITDA now vs peer median 10.1xmedian 10.1x —median 12.9x -2.5xmedian 10.1x
P/FCF now vs peer median 17.7xmedian 15.9x 12.2xmedian 15.5x -0.5xmedian 15.9x
P/B now vs peer median 1.8xmedian 1.5x 5.8xmedian 1.7x 0.6xmedian 1.5x
PEG now vs peer median -1.59median 0.80 1.24median 1.68 —median 0.80

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsAMCRAVYDSS
Revenue $23.51B $9.36B $18.17M
Gross profit $4.69B $2.70B –
Operating income $1.90B – -$16.42M
Net income $1.11B $708.30M -$31.02M
Free cash flow $1.23B – -$11.04M
R&D $170.00M – –
EPS (diluted) $2.38 $9.27 $-1.75
Cash & equivalents $1.12B $271.40M $4.07M
Total debt $14.01B – $114.74M
Shares (diluted) 463.80M 76.40M 10.04M
Enterprise value $17.21B $13.82B -$20.24M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricAMCRAVYDSS
P/E 19.7x 19.6x -0.3x
P/FCF 17.7x 12.2x -0.5x
P/Operating cash flow 10.1x 11.3x -0.5x
P/S 0.9x 1.5x 0.3x
P/B 1.8x 5.8x 0.6x
P/Tangible book 4.2x 5.8x -0.7x
EV/EBITDA 10.1x – -2.5x
EV/EBIT 18.3x – -2.2x
EV/Revenue 1.5x 1.5x 2.0x
EV/FCF 28.2x – -3.2x
EV/Operating cash flow 16.1x 11.3x -3.3x
PEG (3Y EPS CAGR) -1.59 1.24 –

Growth

14 metrics
MetricAMCRAVYDSS
Revenue growth (1Y) 56.6% 6.8% -63.2%
Revenue CAGR (3Y) 17.0% 4.2% –
Gross profit growth (1Y) 65.5% 7.8% –
Gross profit CAGR (3Y) 19.8% 7.4% –
Operating income growth (1Y) 88.2% – -54.0%
Operating income CAGR (3Y) 8.0% – –
Net income growth (1Y) 113.5% 1.8% 39.8%
Net income CAGR (3Y) 1.5% 13.6% 32.7%
EPS growth (1Y) 48.7% 4.0% -152.5%
EPS CAGR (3Y) -12.4% 15.9% –
Operating cash flow growth (1Y) 54.7% 42.6% -192.8%
Operating cash flow CAGR (3Y) 19.5% 12.4% 31.2%
Free cash flow growth (1Y) 51.7% – -173.9%
Free cash flow CAGR (3Y) 18.7% – 31.3%

Profitability

14 metrics
MetricAMCRAVYDSS
Gross margin 20.0% – –
EBITDA margin 14.6% – -77.5%
Operating margin 8.1% – -90.4%
Pretax margin 5.5% – -106.5%
Net margin 4.7% – -96.5%
FCF margin 5.2% – -60.7%
Operating cash flow margin 9.2% 13.0% -58.7%
Return on equity 9.4% – -183.8%
Return on assets 3.0% – -27.6%
Return on invested capital 6.1% – –
Return on capital employed 6.4% – -79.9%
Asset turnover 0.6x 1.0x 0.3x
Cash conversion (OCF / net income) 1.9x 1.7x 0.3x
Stock comp / revenue 0.4% 0.3% 14.9%

Financial Health

11 metrics
MetricAMCRAVYDSS
Debt / assets 37.8% – 52.1%
Debt / equity 1.2x – 4.2x
Net debt / EBITDA 3.8x – -2.2x
Debt / FCF 11.4x – -3.2x
Liabilities / assets 68.2% – 87.6%
Equity / assets 31.8% 26.1% 12.4%
Interest coverage 2.8x – -57.8x
Current ratio 1.3x 1.2x 0.2x
Quick ratio 0.6x – 0.1x
Cash ratio 0.1x – 0.1x
Altman Z-score 1.40 – -8.09

Shareholder Returns

7 metrics
MetricAMCRAVYDSS
Dividend yield 11.0% 2.1% –
Net buyback yield 0.0% – -31.9%
Shareholder yield 11.0% 2.1% -31.9%
Payout ratio (earnings) 108.0% – –
Payout ratio (FCF) 97.2% – –
Dividend growth (1Y) 41.4% – –
Dividend CAGR (3Y) 18.2% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusAMCRAVYDSS
Forward P/E 11.4xFY2027 17.2xFY2026 –
EPS, next fiscal year $4.12FY2027 $10.61FY2026 $-1.33FY2026
EPS growth, next FY +2.5%FY2027 +11.3%FY2026 –
EPS growth, the year after +9.2% +7.9% –
Revenue, next fiscal year $23.41BFY2027 $9.82BFY2026 $19.07MFY2026
Revenue growth, next FY -0.4%FY2027 +10.9%FY2026 -8.1%FY2026
Revenue growth, the year after -2.2% +0.1% +3.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersAMCRAVYDSS
Held by institutions 77.1% 97.4% –
Institutions holding 685 784 –
Change in shares held, QoQ +3.7% +2.7% –
Institutions buying 410 384 –
Institutions selling 211 272 –
Buyers to sellers 1.94 1.41 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

AMCRAVYDSS
AMCR 1.00 0.69 -0.08
AVY 0.69 1.00 -0.06
DSS -0.08 -0.06 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, AMCR, AVY and DSS?

Amcor (AMCR) is the largest by market capitalisation: Amcor (AMCR) $21.79B, Avery Dennison (AVY) $13.82B, Dss (DSS) $5.22M.

Which stock is cheaper, AMCR, AVY and DSS?

Avery Dennison (AVY) trades on the lowest price-to-earnings ratio (Amcor (AMCR) 19.7x, Avery Dennison (AVY) 19.6x, Dss (DSS) -0.3x). On next year's consensus earnings, Amcor (AMCR) is cheapest (Amcor (AMCR) 11.4x, Avery Dennison (AVY) 17.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Amcor (AMCR) grew revenue fastest over the trailing twelve months: Amcor (AMCR) +56.6%, Avery Dennison (AVY) +6.8%, Dss (DSS) -63.2%.

Which company is more profitable?

Amcor (AMCR) has the highest net margin (Amcor (AMCR) 4.7%, Dss (DSS) -96.5%).

Which stock has performed better?

Over the past year Amcor (AMCR) returned the most: Amcor (AMCR) +17.8%, Avery Dennison (AVY) +3.4%, Dss (DSS) -56.3%. Over five years, Avery Dennison (AVY) compounded fastest (Amcor (AMCR) -4.8%/yr, Avery Dennison (AVY) -3.5%/yr, Dss (DSS) -53.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Amcor (AMCR) has the highest dividend yield: Amcor (AMCR) 11.04%, Avery Dennison (AVY) 2.13%. Dss (DSS) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Avery Dennison (AVY) has been the steadiest (Amcor (AMCR) 31.4%, Avery Dennison (AVY) 23.4%, Dss (DSS) 102.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, AMCR, AVY and DSS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Amcor (AMCR) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.